Directori de persones
Judit Herreros Danés

Judit Herreros Danés

Grau: Doctor/a

973 702 950
judit.herreros(ELIMINAR)@udl.cat

ResearcherID: http://www.researcherid.com/rid/B-5809-2009

Grups

Publicacions

  • Bhardwaj, D; Nager, M; Visa, A; Sallan, MC; Coopman, PJ; Canti, C; Herreros, J

    Phosphorylated Tyr142 beta-catenin localizes to centrosomes and is regulated by Syk

    Journal Of Cellular Biochemistry 119 3632-3640. .

    [doi:10.1002/jcb.26571]

  • Nager, M; Sallan, MC; Visa, A; Pushparaj, C; Santacana, M; Macia, A; Yeramian, A; Canti, C; Herreros, J

    Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers

    Autophagy 14 619-636. .

    [doi:10.1080/15548627.2017.1423439]

  • Sallan, MC; Visa, A; Shaikh, S; Nager, M; Herreros, J; Canti, C

    T-type Ca2+ Channels: T for Targetable

    CANCER RESEARCH 78 603-609. .

    [doi:10.1158/0008-5472.CAN-17-3061]

  • Barcelo, C; Maiques, O; Panosa, A; Pijuan, J; Orgaz, JL; Vilella, R; Fabra, A; Puig, S; Sanz-Moreno, V; Matias-Guiu, X; Herreros, J; Canti, C; Macia, A; Marti, RM

    T-type calcium channel blockers reduce migration/invasion in BRAFV600E melanoma cells by inhibiting autophagy

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 31 66-66. .

  • Maiques, O; Macia, A; Moreno, S; Barcelo, C; Santacana, M; Vea, A; Herreros, J; Gatius, S; Ortega, E; Valls, J; Chen, BJ; Llobet-Navas, D; Matias-Guiu, X; Canti, C; Marti, RM

    Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma

    BRITISH JOURNAL OF DERMATOLOGY 176 1247-1258. .

    [doi:10.1111/bjd.15121]

  • Pushparaj, C; Das, A; Purroy, R; Nàger, M.; Herreros, J; Pamplona, R; Canti, C

    Voltage-gated calcium channel blockers deregulate macroautophagyin cardiomyocytes (vol 68, pg 166, 2015)

    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY 70 173-173. .

    [doi:10.1016/j.biocel.2015.11.011]

  • Macia, A; Herreros, J; Marti, RM; Canti, C

    Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma (vol 2015, 587138, 2015)

    BioMed Research International 2016 3017536-3017536. .

    [doi:10.1155/2016/3017536]

  • Nager, M; Santacana, M; Bhardwaj, D; Valls, J; Ferrer, I; Nogues, P; Canti, C; Herreros, J

    Nuclear phosphorylated Y142 beta-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion

    CELL CYCLE 14 3644-3655. .

    [doi:10.1080/15384101.2015.1104443]

  • Pushparaj C; Das A; Purroy R; Nàger M; Herreros J; Pamplona R; Cantí C

    Voltage-gated calcium channel blockers deregulate macroautophagy in cardiomyocytes

    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY 68 166-175. .

    [doi:10.1016/j.biocel.2015.09.010]

  • Macia, A.; Herreros, J.; Marti, R. M.; Canti, C.

    Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma

    BioMed Research International 2015 -. .

    [doi:10.1155/2015/587135]

  • Cornago M; Garcia-Alberich C; Blasco-Angulo N; Vall-Llaura N; Nager M; Herreros J; Comella JX; Sanchis D; Llovera M

    Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe

    CELL DEATH & DISEASE 5 -. .

    [doi:10.1038/cddis.2014.412]

  • Das, Arindam; Pushparaj, Charumathi; Herreros, Judit; Nager, Mireia; Vilella, Ramon; Portero, Manuel; Pamplona, Reinald; Matias-Guiu, Xavier; Marti, Rosa M.; Canti, Carles

    T-type calcium channel blockers inhibit autophagy and promote apoptosis of malignant melanoma cells

    PIGMENT CELL & MELANOMA RESEARCH 26 874-885. .

    [doi:10.1111/pcmr.12155]

Projectes

  • Disrupción del contexto protumoral del glioblastoma: modulación de canales iónicos en las distintas poblaciones celulares implicadas
  • INVESTIGO 2022: Senyalització cel·lular per calci
  • Targeting calcium channels against primary and resistant glioblastoma
  • Nuevos mecanismos de desregulación de la señalización por calcio contra el glioblastoma
  • POSTDOCTORAL AECC 2017: ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA HUMANO. ESTUDIO DE LAS RESISTENCIAS A FARMACOS CONVENCIONALES Y EL PROCESO AUTOFAGICO
  • IMPLEMENTATION OF PERSONALIZE MEDICINE IN CUTANEOUS MELANOMA BASED ON GENOMIC SUSCEPTIBILITY AND TUMOR SIGNATURES: IDENTIFICATION OF NEW TARGETS FOR MELANOMA TREATMENT
  • Regulación del flujo autofágico en el glioblastoma multiforme: hacia la identificación de nuevas estrategias terapéuticas
  • FUNCION DE BETA-CATENINA DURANTE LA DIFERENCIACION NEURONAL Y EN LA INVASIVIDAD DE CELULAS TUMORALES CEREBRALES: PAPEL DE LA FOSFORILACION EN TIROSINA